Evidence map›Paper›PMID 26675350›Full record

ArticleBlood2016

Human STEAP3 mutations with no phenotypic red cell changes.

Dun Liu, Sheng Yi, Xinhua Zhang, Ping Fang, Chenguang Zheng, Li Lin, Ren Cai, Yuhua Ye, Yuqiu Zhou, Yunhao Liang and 6 more

Open access · bronzeAbstract readLetter
In one paragraph

Article in Blood, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Targeting iron metabolism in drug discovery and delivery.Nature reviews. Drug discovery · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Dun LiuDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Sheng YiDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Xinhua ZhangDepartment of Hematology, 303rd Hospital of the People's Liberation Army, Nanning, Guangxi, China;
Ping FangDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Chenguang ZhengPrenatal Diagnostic Center, Guangxi Zhuang Autonomous Region Women and Children Care Hospital, Nanning, Guangxi, China;
Li LinDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Ren CaiDepartment of Birth Health and Heredity, Liuzhou Women and Children Care Hospital, Liuzhou, Guangxi, China;
Yuhua YeDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Yuqiu ZhouDepartment of Birth Health and Heredity, Zhuhai Women and Children Care Hospital, Zhuhai, Guangdong, China; and.
Yunhao LiangDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Feng ChengDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Xuelian ZhangDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Wanjun ZhouDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Narla MohandasRed Cell Physiology Laboratory, New York Blood Center, New York, NY.
Xiuli AnRed Cell Physiology Laboratory, New York Blood Center, New York, NY.
Xiangmin XuDepartment of Medical Genetics, School of Basic Medical Sciences, Southern Medical University, Guangzhou, Guangdong, China;
Southern Medical University · CNNew York Blood Center · US303 Hospital of People's Liberation Army · CNLiuzhou Maternal and Child Health Hospital · CN

Funding

RED CELL DEFORMABILITY IN VITRO AND SURVIVAL IN VIVOR37DK026263 · NIDDK · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI NARLA, MOHANDAS · 1995 to 2017
$4.5M
RED CELL DEFORMABILITY IN VITRO AND SURVIVAL IN VIVOR01DK026263 · NIDDK · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI NARLA, MOHANDAS · 1986 to 2007
$1.6M
NIDDK NIH HHS DK026263NIDDK NIH HHS R37 DK026263
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alpha-ThalassemiaAsian PeopleBase SequenceCell Cycle ProteinsChinaErythrocytesFemaleHeterozygoteHumansMaleMicroscopy, ConfocalMolecular Sequence DataMutationOncogene ProteinsOxidoreductasesPedigreeCell Cycle ProteinsOncogene ProteinsOxidoreductasesSTEAP3 protein, human

Identifiers

PMID26675350
PMCPMC4768430
OpenAlexW2346653742

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.